Read the rest here:
SCYNEXIS Announces Submission of Supplemental New Drug Application of BREXAFEMME® (ibrexafungerp tablets) to the U.S. Food and Drug Administration...
Category Archives: Global News Feed
Terns Pharmaceuticals Highlights Results from Phase 1 Clinical Trial of TERN-501 at AASLD The Liver Meeting® 2022
Read more from the original source:
Terns Pharmaceuticals Highlights Results from Phase 1 Clinical Trial of TERN-501 at AASLD The Liver Meeting® 2022
Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
ExCellThera announces oral presentation of new data on UM171-expanded cell therapy at the ASH Annual Meeting
Terns Pharmaceuticals to Present Positive Clinical Data in NASH at AASLD The Liver Meeting® 2022
Santhera Submits Marketing Authorization Application to the European Medicines Agency for Vamorolone in Duchenne Muscular Dystrophy
DEINOVE – Extraordinary General Meeting of October 17, 2022: Appointment of an ad hoc representative
Spectral Announces Second Quarter Results and Provides Corporate Update
Bespoke Extracts to Expand its Colorado Business and Capabilities with Acquisition of Best Day Ever
Checkpoint Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
PepGen Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
Jasper Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
View original post here:
Jasper Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
Clene to Host VISIONARY-MS Results Call and Webcast on August 15
Read this article:
Clene to Host VISIONARY-MS Results Call and Webcast on August 15
BioCorRx Featured on LiveNOW from FOX
Read more:
BioCorRx Featured on LiveNOW from FOX
Agra Ventures Announces Results of its Annual General & Special Meeting
Read this article:
Agra Ventures Announces Results of its Annual General & Special Meeting
CENTOGENE Announces Appointment of Miguel Coego Rios as Chief Financial Officer
Allogene Therapeutics Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to ALLO-501A for Large B Cell Lymphoma
First patient dosed in second Phase 2 add-on Ketamine Trial in Treatment-Resistant Depression (TRD)
Go here to read the rest:
First patient dosed in second Phase 2 add-on Ketamine Trial in Treatment-Resistant Depression (TRD)
Albireo to Present New Data at the EASL International Liver Congress™ 2022
Originally posted here:
Albireo to Present New Data at the EASL International Liver Congress™ 2022
CorMedix to Participate at the JMP Securities Life Sciences Conference
Go here to read the rest:
CorMedix to Participate at the JMP Securities Life Sciences Conference